Genetic approaches to understanding human obesity

Journal of Clinical Investigation

Volumn 121, Issue 6, 2011, Pages 2080-2086

  Ramachandrappa, Shwetha ^a   Farooqi, I Sadaf ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; MELANOCORTIN; MELANOCORTIN RECEPTOR AGONIST;

ALBRIGHT SYNDROME; BARDET BIEDL SYNDROME; BLOOD PRESSURE; BODY WEIGHT; CALORIC INTAKE; COMORBIDITY; COPY NUMBER VARIATION; ENERGY; ENERGY EXPENDITURE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HERITABILITY; HOMEOSTASIS; HUMAN; NONHUMAN; NUTRITION; OBESITY; OXIDATION; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PUBERTY; REVIEW; SYMPATHETIC TONE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BODY WEIGHT; DIETARY FATS; ENERGY METABOLISM; ENVIRONMENT; GENE DOSAGE; GENETIC ASSOCIATION STUDIES; GENOME-WIDE ASSOCIATION STUDY; GENOMIC IMPRINTING; HUMANS; LEPTIN; MELANOCORTINS; MICE; MICE, MUTANT STRAINS; OBESITY; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, LEPTIN; SYNDROME;

EID: 79957925582     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI46044     Document Type: Review

References (112)

1. Friedman JM. Obesity in the new millennium. Nature. 2000;404(6778):632- 634. (Pubitemid 30205067)
2. Wardle J, Carnell S, Haworth CM, Plomin R. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr. 2008;87(2):398-404. (Pubitemid 351226077)
3. Barsh GS, Farooqi IS, O'Rahilly S. Genetics of bodyweight regulation. Nature. 2000;404(6778):644-651.
4. Allison DB, Kaprio J, Korkeila M, Koskenvuo M, Neale MC, Hayakawa K. The heritability of body mass index among an international sample of monozygotic twins reared apart. Int J Obes Relat Metab Disord. 1996;20(6):501-506. (Pubitemid 26174333)
5. Stunkard AJ, Foch TT, Hrubec Z. A twin study of human obesity. Jama. 1986;256(1):51-54. (Pubitemid 16093199)
6. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart [see comments]. N Engl J Med. 1990;322(21):1483-1487. (Pubitemid 20179861)
7. Haworth CM, Plomin R, Carnell S, Wardle J. Childhood obesity: genetic and environmental overlap with normal-range BMI. Obesity (Silver Spring). 2008;16(7):1585-1590. (Pubitemid 351915111)
8. Sorensen TI, Price RA, Stunkard AJ, Schulsinger F. Genetics of obesity in adult adoptees and their biological siblings. BMJ. 1989;298(6666):87-90. (Pubitemid 19032931)
9. Bouchard C, et al. The response to long-term overfeeding in identical twins [see comments]. N Engl J Med. 1990;322(21):1477-1482. (Pubitemid 20179860)
10. Bouchard C, et al. Overfeeding in identical twins: 5-year postoverfeeding results. Metabolism. 1996;45(8):1042-1050. (Pubitemid 26282561)
11. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond B Biol Sci. 1953;140(901)578-596.
12. Anand BK, Brobeck JR. Hypothalamic control of food intake in rats and cats. Yale J Biol Med. 1951;24(2):123-146.
13. Hervey GR. The effects of lesions in the hypothalamus in parabiotic rats. J Physiol London. 1959;145(2):336.
14. Coleman DL, Hummel KP. Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol. 1969;217(5):1298-1304.
15. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue [published erratum appears in Nature 1995 Mar 30;374(6521):479] [see comments]. Nature. 1994;372(6505):425-432. (Pubitemid 24365442)
16. Maffei M, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1(11):1155-1161.
17. Considine RV, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans [see comments]. N Engl J Med. 1996;334(5):292-295. (Pubitemid 26033933)
18. Ahima RS, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382(6588):250-252.
19. Chen H, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 1996;84(3):491-495. (Pubitemid 26060722)
20. Elmquist JK, Bjorbaek C, Ahima RS, Flier JS, Saper CB. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol. 1998;395(4):535-547. (Pubitemid 28226097)
21. Cone RD. Anatomy and regulation of the central melanocortin system. Nat Neurosci. 2005;8(5):571-578. (Pubitemid 40594196)
22. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404(6778):661-671. (Pubitemid 30205071)
23. Huszar D, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88(1):131-141. (Pubitemid 27180337)
24. Montague CT, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387(6636):903-908. (Pubitemid 27289591)
25. Gibson WT, et al. Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy. J Clin Endocrinol Metab. 2004;89(10):4821-4826. (Pubitemid 39391413)
26. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet. 1998;18(3):213-215.
27. Farooqi IS, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999;341(12):879-884. (Pubitemid 29427050)
28. Farooqi IS, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110(8):1093-1103.
29. Farooqi IS, et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med. 2007;356(3):237-247. (Pubitemid 46143227)
30. Clement K, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction [see comments]. Nature. 1998;392(6674):398- 401. (Pubitemid 28168737)
31. Licinio J, et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A. 2004;101(13):4531-4536. (Pubitemid 38437445)
32. Farooqi IS, Bullmore E, Keogh J, Gillard J, O'Rahilly S, Fletcher PC. Leptin regulates striatal regions and human eating behavior. Science. 2007;317(5843):1355. (Pubitemid 47417470)
33. Rosenbaum M, Sy M, Pavlovich K, Leibel RL, Hirsch J. Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J Clin Invest. 2008;118(7):2583-2591. (Pubitemid 351949785)
34. Fulton S, et al. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron. 2006;51(6):811-822. (Pubitemid 44374918)
35. Hommel JD, et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron. 2006;51(6):801-810. (Pubitemid 44374908)
36. Galgani JE, Greenway FL, Caglayan S, Wong ML, Licinio J, Ravussin E. Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptin-deficient patients. J Clin Endocrinol Metab. 2010;95(2):851-855.
37. Rosenbaum M, et al. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest. 2005;115(12):3579-3586. (Pubitemid 43121846)
38. Minokoshi Y, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 2002;415(6869):339-343. (Pubitemid 34087557)
39. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab. 1999;84(10):3686-3695. (Pubitemid 30645226)
40. Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab. 2002;87(5):2391-2394. (Pubitemid 34521535)
41. Chan YM, Broder-Fingert S, Seminara SB. Reproductive functions of kisspeptin and Gpr54 across the life cycle of mice and men. Peptides. 2009;30(1):42-48.
42. Donato J Jr, et al. Leptin's effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons. J Clin Invest. 2011;121(1):355-368.
43. Tschop J, et al. CNS leptin action modulates immune response and survival in sepsis. J Neurosci. 2010;30(17):6036-6047.
44. Nagajyothi F, et al. Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection. J Infect Dis. 2010;202(7):1104-1113.
45. Matarese G, Moschos S, Mantzoros CS. Leptin in immunology. J Immunol. 2005;174(6):3137-3142. (Pubitemid 40354011)
46. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 1998;19(2):155-157. (Pubitemid 28248796)
47. Krude H, et al. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab. 2003;88(10):4633-4640. (Pubitemid 37357504)
48. Farooqi IS, et al. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes. 2006;55(9):2549-2553. (Pubitemid 44871155)
49. Lee YS, et al. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006;3(2):135-140.
50. Biebermann H, et al. A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 2006;3(2):141-146.
51. Creemers JW, et al. Mutations in the amino-terminal region of proopiomelanocortin (POMC) in patients with early-onset obesity impair POMC sorting to the regulated secretory pathway. J Clin Endocrinol Metab. 2008;93(11):4494-4499. (Pubitemid 352789552)
52. Jackson RS, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene [see comments]. Nat Genet. 1997;16(3):303-306. (Pubitemid 27280217)
53. Jackson RS, et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest. 2003;112(10):1550-1560. (Pubitemid 38056281)
54. Farooqi IS, et al. Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3. J Clin Endocrinol Metab. 2007;92(9):3369-3373. (Pubitemid 47435306)
55. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003;348(12):1085-1095. (Pubitemid 36337319)
56. Alharbi KK, et al. Prevalence and functionality of paucimorphic and private MC4R mutations in a large, unselected European British population, scanned by meltMADGE. Hum Mutat. 2007;28(3):294-302.
57. Farooqi IS, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest. 2000;106(2):271-279. (Pubitemid 30483131)
58. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest. 2000;106(2):253-262. (Pubitemid 30483129)
59. Stutzmann F, et al. Prevalence of MC4R deficiency in European population and their age-dependant penetrance in multi-generational pedigrees. Diabetes. 2008;57(9):2511-2518.
60. Lubrano-Berthelier C, et al. Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. J Clin Endocrinol Metab. 2006;91(5):1811-1818.
61. Farooqi IS. The severely obese patient - a genetic work-up. Nat Clin Pract Endocrinol Metab. 2006;2(3):172-177.
62. Rene P, et al. Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity. J Pharmacol Exp Ther. 2010;335(3):520-532.
63. Nogueiras R, et al. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest. 2007;117(11):3475-3488. (Pubitemid 350097003)
64. Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE. Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension. 2005;46(2):326-332. (Pubitemid 41099165)
65. Greenfield JR, et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med. 2009;360(1):44-52.
66. Greenfield JR. Melanocortin signalling and the regulation of blood pressure in human obesity. J Neuroendocrinol. 2011;23(2):186-193.
67. Martinelli CE, et al. Obesity due to Melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion. J Clin Endocrinol Metab. 2011;96(1):E181-E188.
68. Martin NM, et al. Abnormalities of the somatotrophic axis in the obese agouti mouse. Int J Obes (Lond). 2006;30(3):430-438.
69. Xu B, et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin 4 receptor. Nat Neurosci. 2003;6(7):736-742. (Pubitemid 36792889)
70. Yeo GS, et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci. 2004;7(11):1187-1189. (Pubitemid 39426236)
71. Gray J, et al. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes. 2006;55(12):3366-3371. (Pubitemid 44923594)
72. Han JC, et al. Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med. 2008;359(9):918-927.
73. Holder JL Jr, Butte NF, Zinn AR. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum Mol Genet. 2000;9(1):101-108. (Pubitemid 30145294)
74. Hung CC, et al. Studies of the SIM1 gene in relation to human obesity and obesity-related traits. Int J Obes (Lond). 2007;31(3):429-434.
75. Michaud JL, et al. Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum Mol Genet. 2001;10(14):1465-1473. (Pubitemid 32684888)
76. Tolson KP, Gemelli T, Gautron L, Elmquist JK, Zinn AR, Kublaoui BM. Postnatal Sim1 deficiency causes hyperphagic obesity and reduced Mc4r and oxytocin expression. J Neurosci. 2010;30(10):3803-3812.
77. Kublaoui BM, Holder JL Jr, Gemelli T, Zinn AR. Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons. Mol Endocrinol. 2006;20(10):2483-2492. (Pubitemid 44496416)
78. Kublaoui BM, Gemelli T, Tolson KP, Wang Y, Zinn AR. Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol Endocrinol. 2008;22(7):1723-1734. (Pubitemid 351920403)
79. Tobin JL, Beales PL. Bardet-Biedl syndrome: beyond the cilium. Pediatr Nephrol. 2007;22(7):926-936. (Pubitemid 46881909)
80. Ansley SJ, et al. Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature. 2003;425(6958):628-633. (Pubitemid 37280147)
81. Ainsworth C. Cilia: tails of the unexpected. Nature. 2007;448(7154):638- 641. (Pubitemid 47236838)
82. Seo S, Guo DF, Bugge K, Morgan DA, Rahmouni K, Sheffield VC. Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. Hum Mol Genet. 2009;18(7):1323-1331.
83. Davenport JR, et al. Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr Biol. 2007;17(18):1586-1594. (Pubitemid 47380400)
84. Sahoo T, et al. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet. 2008;40(6):719-721. (Pubitemid 351748873)
85. de Smith AJ, et al. A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism. Hum Mol Genet. 2009;18(17):3257-3265.
86. Cummings DE, et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med. 2002;8(7):643-644. (Pubitemid 34778697)
87. Haqq AM, et al. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab. 2003;88(1):174-178. (Pubitemid 36115161)
88. Swaab DF, Purba JS, Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab. 1995;80(2):573-579.
89. Weinstein LS, Chen M, Liu J. Gs(alpha) mutations and imprinting defects in human disease. Ann N Y Acad Sci. 2002;968:173-197. (Pubitemid 34721880)
90. Chen M, et al. Central nervous system imprinting of the G protein G(s)alpha and its role in metabolic regulation. Cell Metab. 2009;9(6):548-555.
91. Bochukova EG, et al. Large, rare chromosomal deletions associated with severe early-onset obesity. Nature. 2010;463(7281):666-670.
92. Walters RG, et al. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature. 2010;463(7281):671-675.
93. Ren D, Li M, Duan C, Rui L. Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. Cell Metab. 2005;2(2):95-104.
94. Frayling TM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889-894. (Pubitemid 46764279)
95. Dina C, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39(6):724-726. (Pubitemid 46848595)
96. Loos RJ, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008;40(6):768-775. (Pubitemid 351748863)
97. Speliotes EK, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42(11):937-948.
98. Wardle J, Carnell S, Haworth CM, Farooqi IS, O'Rahilly S, Plomin R. Obesity-associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab. 2008;93(9):3640-3643.
99. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med. 2008;359(24):2558-2566.
100. Gerken T, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007;318(5855):1469- 1472. (Pubitemid 350208961)
101. Stratigopoulos G, et al. Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol. 2008;294(4):R1185-R1196. (Pubitemid 351490637)
102. Fischer J, et al. Inactivation of the Fto gene protects from obesity. Nature. 2009;458(7240):894-898.
103. Church C, et al. Overexpression of Fto leads to increased food intake and results in obesity. Nat Genet. 2010;42(12):1086-1092.
104. Willer CJ, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009;41(1):25-34.
105. Thorleifsson G, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet. 2009;41(1):18-24.
106. Ng SB, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature. 2009;461(7261):272-276.
107. Roach JC, et al. Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science. 2010;328(5978):636-639.
108. Price AL, et al. Pooled association tests for rare variants in exon-resequencing studies. Am J Hum Genet. 2010;86(6):832-838.
109. Bulik CM, Allison DB. The genetic epidemiology of thinness. Obes Rev. 2001;2(2):107-115. (Pubitemid 33755920)
110. Ng SB, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet. 2010;42(1):30-35.
111. McCurdy CE, et al. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest. 2009;119(2):323-335.
112. Feinberg AP, et al. Personalized epigenomic signatures that are stable over time and covary with body mass index. Sci Transl Med. 2010;2(49):49ra67.